In vitro treatment with anti-PD-L1 induced more CLL cell death in T-cell cytotoxicity assays in samples obtained from patients treated with ibrutinib compared to those treated with chemoimmunotherapy [58]. This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.